Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$354.9 - $412.41 $207,971 - $241,672
586 Added 20.99%
3,378 $1.27 Million
Q2 2023

Aug 14, 2023

SELL
$334.63 - $382.47 $1.07 Million - $1.22 Million
-3,186 Reduced 53.3%
2,792 $1.07 Million
Q1 2023

May 15, 2023

BUY
$232.5 - $346.47 $371,535 - $553,659
1,598 Added 36.48%
5,978 $2.07 Million
Q4 2022

Feb 14, 2023

SELL
$209.34 - $261.61 $209 - $261
-1 Reduced 0.02%
4,380 $1.03 Million
Q3 2022

Nov 14, 2022

SELL
$246.08 - $343.65 $2.24 Million - $3.13 Million
-9,118 Reduced 67.55%
4,381 $1.08 Million
Q2 2022

Aug 15, 2022

BUY
$280.61 - $420.45 $729,305 - $1.09 Million
2,599 Added 23.84%
13,499 $4.08 Million
Q4 2021

Feb 14, 2022

SELL
$402.25 - $471.34 $201,929 - $236,612
-502 Reduced 4.4%
10,900 $5.11 Million
Q3 2021

Nov 15, 2021

BUY
$363.01 - $468.47 $4.14 Million - $5.34 Million
11,402 New
11,402 $4.84 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.